Alvelestat (MPH966)
IRB-300002338
Phase 2 small_molecule completed
Quick answer
Alvelestat (MPH966) for Alpha-1 Antitrypsin Deficiency (AATD) is a Phase 2 program (small_molecule) at Mereo BioPharma Group plc with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Mereo BioPharma Group plc
- Indication
- Alpha-1 Antitrypsin Deficiency (AATD)
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- completed